English
Русский
English
References of the article: “Immune thrombocytopenia: what can the systems biology and systems physiology offer?”
  1. International consensus report on the investigation and management of primary immune thrombocytopenia

    D. Provan, R. Stasi, A. Newland, V. Blanchette, P. Bolton-Maggs, J. Bussel, B. Chong, D. Cines, T. Gernsheimer, B. Godeau, J. Grainger, I. Greer, B. Hunt, P. Imbach, G. Lyons, R. McMillan, F. Rodeghiero, M. Sanz, M. Tarantino, S. Watson, J. Young, D. Kuter

    Blood. 2010, 115, 168-186

    https://doi.org/10.1182/blood-2009-06-225565

    Article|Google Scholar

  2. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

    C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg, M. Crowther

    Blood. 2011, 117, 4190-4207

    https://doi.org/10.1182/blood-2010-08-302984

    Article|Google Scholar

  3. Chronic Immune Thrombocytopenia in Adults: Epidemiology and Clinical Presentation

    P. Fogarty

    Hematology/Oncology Clinics of North America. 2009, 23, 1213-1221

    https://doi.org/10.1016/j.hoc.2009.08.004

    Article|Google Scholar

  4. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database

    M. Yong, W. Schoonen, L. Li, G. Kanas, J. Coalson, F. Mowat, J. Fryzek, J. Kaye

    British Journal of Haematology. 2010, 149, 855-864

    https://doi.org/10.1111/j.1365-2141.2010.08176.x

    Article|Google Scholar

  5. Platelet Autoantibodies in Immune Thrombocytopenic Purpura

    D. Beardsley, M.D., Ph.D, M. Ertem, M.D

    Transfusion Science. 1998, 19, 237-244

    https://doi.org/10.1016/S0955-3886(98)00037-X

    Article|Google Scholar

  6. Specificity of autoantibodies in autoimmune thrombocytopenia

    van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE.

    Blood. 1982, 59, 23-26

    Google Scholar

  7. SIMILARITIES BETWEEN KNOWN ANTIPLATELET ANTIBODIES AND THE FACTOR RESPONSIBLE FOR THROMBOCYTOPENIA IN IDIOPATHIC PURPURA. PHYSIOLOGIC, SEROLOGIC AND ISOTOPIC STUDIES

    N. Shulman, V. Marder, R. Weinrach

    Annals of the New York Academy of Sciences. 2006, 124, 499-542

    https://doi.org/10.1111/j.1749-6632.1965.tb18984.x

    Article|Google Scholar

  8. Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry

    D. Arnold, I. Nazy, R. Clare, A. Jaffer, B. Aubie, N. Li, J. Kelton

    Blood Advances. 2017, 1, 2414-2420

    https://doi.org/10.1182/bloodadvances.2017010942

    Article|Google Scholar

  9. Pathobiology of Secondary Immune Thrombocytopenia

    D. Cines, H. Liebman, R. Stasi

    Seminars in Hematology. 2009, 46, S2-S14

    https://doi.org/10.1053/j.seminhematol.2008.12.005

    Article|Google Scholar

  10. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis

    H. Zhao, S. Li, R. Yang

    Platelets. 2010, 21, 380-385

    https://doi.org/10.3109/09537101003735564

    Article|Google Scholar

  11. Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

    R. Tomasello, G. Giordano, F. Romano, F. Vaccarino, S. Siragusa, A. Lucchesi, M. Napolitano

    Biomedicines. 2021, 9, 1170

    https://doi.org/10.3390/biomedicines9091170

    Article|Google Scholar

  12. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C–related immunologic thrombocytopenia

    W. Zhang, M. Nardi, W. Borkowsky, Z. Li, S. Karpatkin

    Blood. 2009, 113, 4086-4093

    https://doi.org/10.1182/blood-2008-09-181073

    Article|Google Scholar

  13. Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia

    Z. Li, M. Nardi, S. Karpatkin

    Blood. 2005, 106, 572-576

    https://doi.org/10.1182/blood-2005-01-0243

    Article|Google Scholar

  14. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori -associated chronic idiopathic thrombocytopenic purpura

    T. Takahashi, T. Yujiri, K. Shinohara, Y. Inoue, Y. Sato, Y. Fujii, M. Okubo, Y. Zaitsu, K. Ariyoshi, Y. Nakamura, R. Nawata, Y. Oka, M. Shirai, Y. Tanizawa

    British Journal of Haematology. 2004, 124, 91-96

    https://doi.org/10.1046/j.1365-2141.2003.04735.x

    Article|Google Scholar

  15. Immune thrombocytopenia in lymphoproliferative diseases

    B. Kaden, W. Rosse, T. Hauch

    Blood. 1979, 53, 545-551

    https://doi.org/10.1182/blood.V53.4.545.545

    Article|Google Scholar

  16. Drug-Induced Immune Thrombocytopenia

    R. Aster, D. Bougie

    New England Journal of Medicine. 2007, 357, 580-587

    https://doi.org/10.1056/NEJMra066469

    Article|Google Scholar

  17. Chronic Idiopathic Thrombocytopenic Purpura

    J. George, M. El-Harake, G. Raskob

    New England Journal of Medicine. 1994, 331, 1207-1211

    https://doi.org/10.1056/NEJM199411033311807

    Article|Google Scholar

  18. Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

    E. Suntsova, A. Maschan, O. Mironenko, D. Baydildina, I. Kalinina, M. Korsantya, N. Kotskaya, Z. Kuzminova, G. Ovsyannikova, U. Petrova, A. Pshonkin, M. Sadovskaya, T. Salimova, N. Trubina, D. Fedorova, G. Novichkova

    Pediatric Hematology/Oncology and Immunopathology. , 20, 12-25

    https://doi.org/10.24287/1726-1708-2021-20-3-12-25

    Article|Google Scholar

  19. First-Line Therapy for Immune Thrombocytopenia

    S. Mithoowani, D. Arnold

    Hämostaseologie. 2019, 39, 259-265

    https://doi.org/10.1055/s-0039-1684031

    Article|Google Scholar

  20. Corticosteroids: The drugs to beat

    P. Barnes

    European Journal of Pharmacology. 2006, 533, 2-14

    https://doi.org/10.1016/j.ejphar.2005.12.052

    Article|Google Scholar

  21. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

    D. Leontyev, Y. Katsman, X. Ma, S. Miescher, F. Käsermann, D. Branch

    Transfusion. 2012, 52, 1799-1805

    https://doi.org/10.1111/j.1537-2995.2011.03517.x

    Article|Google Scholar

  22. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia

    S. Wang, K. Yang, C. Lin, A. Huang, C. Hsiao, M. Lin, Y. Tsai

    Pediatric Blood & Cancer. 2020, 67,

    https://doi.org/10.1002/pbc.28075

    Article|Google Scholar

  23. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults

    F. Borst, J. Keuning, H. van Hulsteijn, H. Sinnige, G. Vreugdenhil

    Annals of Hematology. 2004, 83, 764-768

    https://doi.org/10.1007/s00277-004-0908-1

    Article|Google Scholar

  24. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura

    M. Hou, J. Peng, Y. Shi, C. Zhang, P. Qin, C. Zhao, X. Ji, X. Wang, M. Zhang

    European Journal of Haematology. 2003, 70, 353-357

    https://doi.org/10.1034/j.1600-0609.2003.00076.x

    Article|Google Scholar

  25. Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura

    D. Choudhary, R. Naithani, M. Mahapatra, R. Kumar, P. Mishra, R. Saxena

    Haematologica. 2008, 93, e61-e62

    https://doi.org/10.3324/haematol.13481

    Article|Google Scholar

  26. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

    M. Khellaf, A. Charles-Nelson, O. Fain, L. Terriou, J. Viallard, S. Cheze, J. Graveleau, B. Slama, S. Audia, M. Ebbo, G. Le Guenno, M. Cliquennois, G. Salles, C. Bonmati, F. Teillet, L. Galicier, A. Hot, O. Lambotte, F. Lefrère, S. Sacko, D. Kengue, P. Bierling, F. Roudot-Thoraval, M. Michel, B. Godeau

    Blood. 2014, 124, 3228-3236

    https://doi.org/10.1182/blood-2014-06-582346

    Article|Google Scholar

  27. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    M. Lozano, M. Mingot-Castellano, M. Perera, I. Jarque, R. Campos-Alvarez, T. González-López, G. Carreño-Tarragona, N. Bermejo, M. Lopez-Fernandez, A. de Andrés, D. Valcarcel, L. Casado-Montero, M. Alvarez-Roman, M. Orts, S. Novelli, N. Revilla, J. González-Porras, E. Bolaños, M. Rodríguez-López, E. Orna-Montero, V. Vicente

    Scientific Reports. 2019, 9, 16680

    https://doi.org/10.1038/s41598-019-53209-y

    Article|Google Scholar

  28. Laparoscopic splenectomy for ITP

    R. Friedman, M. Fallas, B. Carroll, J. Hiatt, E. Phillips

    Surgical Endoscopy. 1996, 10, 991-995

    https://doi.org/10.1007/s004649900221

    Article|Google Scholar

  29. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?

    F. Rodeghiero, M. Ruggeri

    British Journal of Haematology. 2012, 158, 16-29

    https://doi.org/10.1111/j.1365-2141.2012.09146.x

    Article|Google Scholar

  30. Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis

    E. Bourgeois, M. Caulier, C. Delarozee, M. Brouillard, F. Bauters, P. Fenaux

    British Journal of Haematology. 2003, 120, 1079-1088

    https://doi.org/10.1046/j.1365-2141.2003.04211.x

    Article|Google Scholar

  31. Anti‐platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications

    D. Schmidt, K. Heitink‐Polle, L. Porcelijn, C. Schoot, G. Vidarsson, M. Bruin, M. Haas

    Journal of Thrombosis and Haemostasis. 2020, 18, 1210-1220

    https://doi.org/10.1111/jth.14762

    Article|Google Scholar

  32. Clinical Role of Antiplatelet Antibody Assays

    R. McMillan

    Seminars in Thrombosis and Hemostasis. 1995, 21, 37-45

    https://doi.org/10.1055/s-2007-1000377

    Article|Google Scholar

  33. Mechanisms of platelet recovery in ITP associated with therapy

    S. Pang, A. Lazarus

    Annals of Hematology. 2010, 89, 31-35

    https://doi.org/10.1007/s00277-010-0916-2

    Article|Google Scholar

  34. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis

    K. Heitink-Pollé, J. Nijsten, C. Boonacker, M. de Haas, M. Bruin

    Blood. 2014, 124, 3295-3307

    https://doi.org/10.1182/blood-2014-04-570127

    Article|Google Scholar

  35. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

    T. Kühne, G. Buchanan, S. Zimmerman, L. Michaels, R. Kohan, W. Berchtold, P. Imbach

    The Journal of Pediatrics. 2003, 143, 605-608

    https://doi.org/10.1067/S0022-3476(03)00535-3

    Article|Google Scholar

  36. ITP following vaccination

    P. David, Y. Shoenfeld

    International Journal of Infectious Diseases. 2020, 99, 243-244

    https://doi.org/10.1016/j.ijid.2020.07.085

    Article|Google Scholar

  37. MMR vaccine and idiopathic thrombocytopaenic purpura

    C. Black, J. Kaye, H. Jick

    British Journal of Clinical Pharmacology. 2003, 55, 107-111

    https://doi.org/10.1046/j.1365-2125.2003.01790.x

    Article|Google Scholar

  38. Spectrum of Ig Classes, Specificities, and Titers of Serum Antiglycoproteins in Chronic Idiopathic Thrombocytopenic Purpura

    He R, Reid DM, Jones C, Shulman NR

    Blood. 1994, 83 (4), 1024-32

    Google Scholar

  39. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia

    V. Kiefel, E. Freitag, H. Kroll, S. Santoso, C. Mueller-Eckhardt

    Annals of Hematology. 1996, 72, 280-285

    https://doi.org/10.1007/s002770050173

    Article|Google Scholar

  40. FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia

    P. Norris, G. Segel, W. Burack, U. Sachs, S. Lissenberg-Thunnissen, G. Vidarsson, B. Bayat, C. Cserti-Gazdewich, J. Callum, Y. Lin, D. Branch, R. Kapur, J. Semple, A. Lazarus

    Haematologica. 2020, 106, 250-254

    https://doi.org/10.3324/haematol.2020.248385

    Article|Google Scholar

  41. Immune Regulatory Function of B Cells

    C. Mauri, A. Bosma

    Annual Review of Immunology. 2012, 30, 221-241

    https://doi.org/10.1146/annurev-immunol-020711-074934

    Article|Google Scholar

  42. Reference values for B cell subpopulations from infancy to adulthood

    H. Morbach, E. Eichhorn, J. Liese, H. Girschick

    Clinical and Experimental Immunology. 2010, 162, 271-279

    https://doi.org/10.1111/j.1365-2249.2010.04206.x

    Article|Google Scholar

  43. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling

    S. Herzog, M. Reth, H. Jumaa

    Nature Reviews Immunology. 2009, 9, 195-205

    https://doi.org/10.1038/nri2491

    Article|Google Scholar

  44. Regulation of plasma-cell development

    M. Shapiro-Shelef, K. Calame

    Nature Reviews Immunology. 2005, 5, 230-242

    https://doi.org/10.1038/nri1572

    Article|Google Scholar

  45. Receptor editing: an approach by autoreactive B cells to escape tolerance.

    D. Gay, T. Saunders, S. Camper, M. Weigert

    Journal of Experimental Medicine. 1993, 177, 999-1008

    https://doi.org/10.1084/jem.177.4.999

    Article|Google Scholar

  46. The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia

    J. Fang, L. Lin, D. Lin, R. Zhang, X. Liu, D. Wang, C. Duan, X. Lin

    Hematology. 2019, 24, 473-479

    https://doi.org/10.1080/16078454.2019.1622292

    Article|Google Scholar

  47. Memory B-cell persistence is independent of persisting immunizing antigen

    M. Maruyama, K. Lam, K. Rajewsky

    Nature. 2000, 407, 636-642

    https://doi.org/10.1038/35036600

    Article|Google Scholar

  48. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia

    X. Zhu, Y. Shi, J. Peng, C. Guo, N. Shan, P. Qin, X. Ji, M. Hou

    Blood. 2009, 114, 5362-5367

    https://doi.org/10.1182/blood-2009-05-217513

    Article|Google Scholar

  49. Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients

    J. Zhai, M. Ding, T. Yang, B. Zuo, Z. Weng, Y. Zhao, J. He, Q. Wu, C. Ruan, Y. He

    Journal of Translational Medicine. 2017, 15, 214

    https://doi.org/10.1186/s12967-017-1317-2

    Article|Google Scholar

  50. Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia

    R. Wen, Y. Wang, Y. Hong, Z. Yang

    Blood Coagulation & Fibrinolysis. 2020, 31, 113-120

    https://doi.org/10.1097/MBC.0000000000000891

    Article|Google Scholar

  51. Immune Thrombocytopenia: A Complex Autoimmune Disease

    Lee E-J, Bussel JB

    The Autoimmune Diseases, Elsevier. 2020, , 911-21

    https://doi.org/10.1016/B978-0-12-812102-3.00048-8

    Article|Google Scholar

  52. Cytotoxic T lymphocytes: all roads lead to death

    M. Barry, R. Bleackley

    Nature Reviews Immunology. 2002, 2, 401-409

    https://doi.org/10.1038/nri819

    Article|Google Scholar

  53. Signal transduction by the TCR for antigen

    L. Kane, J. Lin, A. Weiss

    Current Opinion in Immunology. 2000, 12, 242-249

    https://doi.org/10.1016/S0952-7915(00)00083-2

    Article|Google Scholar

  54. Metabolism in T cell activation and differentiation

    E. Pearce

    Current Opinion in Immunology. 2010, 22, 314-320

    https://doi.org/10.1016/j.coi.2010.01.018

    Article|Google Scholar

  55. Perforin and granzymes: function, dysfunction and human pathology

    I. Voskoboinik, J. Whisstock, J. Trapani

    Nature Reviews Immunology. 2015, 15, 388-400

    https://doi.org/10.1038/nri3839

    Article|Google Scholar

  56. Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation

    V. Sutton, J. Davis, M. Cancilla, R. Johnstone, A. Ruefli, K. Sedelies, K. Browne, J. Trapani

    Journal of Experimental Medicine. 2000, 192, 1403-1414

    https://doi.org/10.1084/jem.192.10.1403

    Article|Google Scholar

  57. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura

    F. Zhang, X. Chu, L. Wang, Y. Zhu, L. Li, D. Ma, J. Peng, M. Hou

    European Journal of Haematology. 2006, 76, 427-431

    https://doi.org/10.1111/j.1600-0609.2005.00622.x

    Article|Google Scholar

  58. Elevated Interleukin-21 Correlated to Th17 and Th1 Cells in Patients with Immune Thrombocytopenia

    X. Zhu, D. Ma, J. Zhang, J. Peng, X. Qu, C. Ji, M. Hou

    Journal of Clinical Immunology. 2010, 30, 253-259

    https://doi.org/10.1007/s10875-009-9353-1

    Article|Google Scholar

  59. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia

    G. Deng, S. Yu, Q. Li, Y. He, W. Liang, L. Yu, D. Xu, T. Sun, R. Zhang, Q. Li

    Hematology. 2017, 22, 155-161

    https://doi.org/10.1080/10245332.2016.1237004

    Article|Google Scholar

  60. Pediatric immune thrombocytopenia: apoptotic markers may help in predicting the disease course

    S. Levy-Mendelovich, S. Aviner, N. Sharon, H. Miskin, J. Yacobovich, G. Kenet, H. Hauschner, N. Rosenberg

    Pediatric Research. 2021, 90, 93-98

    https://doi.org/10.1038/s41390-020-01355-9

    Article|Google Scholar

  61. Regulation of human helper T cell subset differentiation by cytokines

    N. Schmitt, H. Ueno

    Current Opinion in Immunology. 2015, 34, 130-136

    https://doi.org/10.1016/j.coi.2015.03.007

    Article|Google Scholar

  62. CD4+T Cells: Differentiation and Functions

    R. Luckheeram, R. Zhou, A. Verma, B. Xia

    Clinical and Developmental Immunology. 2012, 2012, 1-12

    https://doi.org/10.1155/2012/925135

    Article|Google Scholar

  63. A Three-cell Model for Activation of Naïve T Helper Cells

    A. Corthay

    Scandinavian Journal of Immunology. 2006, 64, 93-96

    https://doi.org/10.1111/j.1365-3083.2006.01782.x

    Article|Google Scholar

  64. TH1 and TH2 cells: a historical perspective

    F. Liew

    Nature Reviews Immunology. 2002, 2, 55-60

    https://doi.org/10.1038/nri705

    Article|Google Scholar

  65. IL-17 and Th17 Cells

    T. Korn, E. Bettelli, M. Oukka, V. Kuchroo

    Annual Review of Immunology. 2009, 27, 485-517

    https://doi.org/10.1146/annurev.immunol.021908.132710

    Article|Google Scholar

  66. IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia

    G. Azizi, R. Yazdani, K. Hamid, A. Razavi, A. Mirshafiey

    Endocrine, Metabolic & Immune Disorders-Drug Targets. 2015, 15, 242-250

    https://doi.org/10.2174/1871530315666150331154733

    Article|Google Scholar

  67. Importance of Th22 Cell Disequilibrium in Immune Thrombocytopenic Purpura

    F. Zhan, J. Li, M. Fang, J. Ding, Q. Wang

    Medical Science Monitor. , 24, 8767-8772

    https://doi.org/10.12659/MSM.912528

    Article|Google Scholar

  68. Effects of High-Dose Dexamethasone on Regulating Interleukin-22 Production and Correcting Th1 and Th22 Polarization in Immune Thrombocytopenia

    J. Cao, C. Chen, L. Li, L. Zeng, Z. Li, Z. Yan, W. Chen, H. Cheng, W. Sang, K. Xu

    Journal of Clinical Immunology. 2012, 32, 523-529

    https://doi.org/10.1007/s10875-012-9649-4

    Article|Google Scholar

  69. The Th1/Th2 balance in autoimmunity

    B. Charlton, K. Lafferty

    Current Opinion in Immunology. 1995, 7, 793-798

    https://doi.org/10.1016/0952-7915(95)80050-6

    Article|Google Scholar

  70. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia

    Y. Hu, H. Li, L. Zhang, B. Shan, X. Xu, H. Li, X. Liu, S. Xu, S. Yu, D. Ma, J. Peng, M. Hou

    Human Immunology. 2012, 73, 629-635

    https://doi.org/10.1016/j.humimm.2012.04.015

    Article|Google Scholar

  71. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia

    A. Rocha, C. Souza, G. Rocha, F. de Melo, N. Clementino, M. Marino, A. Bozzi, M. Silva, O. Martins Filho, D. Queiroz

    Haematologica. 2011, 96, 1560-1564

    https://doi.org/10.3324/haematol.2011.046417

    Article|Google Scholar

  72. The role of different subsets of T regulatory cells in controlling autoimmunity

    M. Roncarolo, M. Levings

    Current Opinion in Immunology. 2000, 12, 676-683

    https://doi.org/10.1016/S0952-7915(00)00162-X

    Article|Google Scholar

  73. FOXP3+ regulatory T cells in the human immune system

    S. Sakaguchi, M. Miyara, C. Costantino, D. Hafler

    Nature Reviews Immunology. 2010, 10, 490-500

    https://doi.org/10.1038/nri2785

    Article|Google Scholar

  74. Regulatory T cell CD4 ‏&CD25‏ expression and chemokine C-X-C ligand 13 level before and after corticosteroid therapy in pediatric ITP patients

    H. Ahmed, E. Fahmy, E. Nagiub Abdelsalam

    Pediatric Hematology Oncology Journal. 2019, 4, 39-43

    https://doi.org/10.1016/j.phoj.2019.08.177

    Article|Google Scholar

  75. Mouse Models for Immune‐Mediated Platelet Destruction or Immune Thrombocytopenia (ITP)

    A. Neschadim, D. Branch

    Current Protocols in Immunology. 2016, 113,

    https://doi.org/10.1002/0471142735.im1530s113

    Article|Google Scholar

  76. Acute Systemic Reaction and Lung Alterations Induced by an Antiplatelet Integrin gpIIb/IIIa Antibody in Mice

    B. Nieswandt, B. Echtenacher, F. Wachs, J. Schröder, J. Gessner, R. Schmidt, G. Grau, D. Männel

    Blood. 1999, 94, 684-693

    https://doi.org/10.1182/blood.V94.2.684

    Article|Google Scholar

  77. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies

    M. Webster, E. Sayeh, M. Crow, P. Chen, B. Nieswandt, J. Freedman, H. Ni

    Blood. 2006, 108, 943-946

    https://doi.org/10.1182/blood-2005-06-009761

    Article|Google Scholar

  78. Pharmacokinetic/Pharmacodynamic Modeling of IVIG Effects in a Murine Model of Immune Thrombocytopenia

    R. Deng, J. Balthasar

    Journal of Pharmaceutical Sciences. 2007, 96, 1625-1637

    https://doi.org/10.1002/jps.20828

    Article|Google Scholar

  79. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell–mediated responses that are differentially sensitive to therapy

    L. Chow, R. Aslam, E. Speck, M. Kim, N. Cridland, M. Webster, P. Chen, K. Sahib, H. Ni, A. Lazarus, M. Garvey, J. Freedman, J. Semple

    Blood. 2010, 115, 1247-1253

    https://doi.org/10.1182/blood-2009-09-244772

    Article|Google Scholar

  80. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia

    L. Ma, E. Simpson, J. Li, M. Xuan, M. Xu, L. Baker, Y. Shi, I. Yougbaré, X. Wang, G. Zhu, P. Chen, G. Prud’homme, A. Lazarus, J. Freedman, H. Ni

    Blood. 2015, 126, 247-256

    https://doi.org/10.1182/blood-2015-03-635417

    Article|Google Scholar

  81. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)

    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M

    J Immunol . 1995, 155, 1151

    Google Scholar

  82. Critical role of CD4+CD25+ regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia

    T. Nishimoto, T. Satoh, T. Takeuchi, Y. Ikeda, M. Kuwana

    Experimental Hematology. 2012, 40, 279-289

    https://doi.org/10.1016/j.exphem.2012.01.001

    Article|Google Scholar

  83. Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia

    T. Nishimoto, M. Numajiri, H. Nakazaki, Y. Okazaki, M. Kuwana

    International Journal of Hematology. 2014, 100, 341-344

    https://doi.org/10.1007/s12185-014-1661-4

    Article|Google Scholar

  84. Of Mice and Not Men: Differences between Mouse and Human Immunology

    J. Mestas, C. Hughes

    The Journal of Immunology. 2004, 172, 2731-2738

    https://doi.org/10.4049/jimmunol.172.5.2731

    Article|Google Scholar

  85. Mathematical Techniques for Understanding Platelet Regulation and the Development of New Pharmacological Approaches

    Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN

    Platelets and Megakaryocytes. 2018, 1812, 255-79

    https://doi.org/10.1007/978-1-4939-8585-2_15

    Article|Google Scholar

  86. Systems approaches meet biology and physiology: why do we need yet another journal?

    M. Panteleev

    System Biology and Physiology Reports. 2021, 1, 1-2

    https://doi.org/10.52455/sbpr.01.202101011

    Article|Google Scholar

  87. Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia

    M. Wire, X. Li, J. Zhang, W. Sallas, V. Aslanis, T. Ouatas

    Clinical Pharmacology & Therapeutics. 2018, 104, 1199-1207

    https://doi.org/10.1002/cpt.1066

    Article|Google Scholar

  88. Heterogeneity of Integrin αIIbβ3 Function in Pediatric Immune Thrombocytopenia Revealed by Continuous Flow Cytometry Analysis

    A. Martyanov, D. Morozova, M. Sorokina, A. Filkova, D. Fedorova, S. Uzueva, E. Suntsova, G. Novichkova, P. Zharkov, M. Panteleev, A. Sveshnikova

    International Journal of Molecular Sciences. 2020, 21, 3035

    https://doi.org/10.3390/ijms21093035

    Article|Google Scholar

  89. A strong correlation exists between platelet consumption and platelet hyperactivation in COVID-19 patients. Pilot study of the patient cohort from CCH RAS Hospital (Troitsk).

    M. Stepanyan, A. Martyanov, O. An, A. Boldova, S. Roumiantsev, A. Rumyantsev, M. Panteleev, F. Ataullakhanov, A. Sveshnikova

    Systems Biology and Physiology Reports. 2021, 1, 1-10

    https://doi.org/10.52455/sbpr.01.202102011

    Article|Google Scholar